Time New York: Fri 14 Dec 09:20 am  |  Save 15% on H&R Block Online


Exact Sciences (EXAS) in Focus: Stock Moves 5.1% Higher


Exact Sciences Corporation EXAS was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $49.91–$57.53 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen one upward estimate revision in the past two months while its Zacks Consensus Estimate for the current quarter has remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Exact Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Exact Sciences Corporation Price and Consensus

A better ranked stock in the Biomedical and Genetics industry is Emergent Biosolutions, Inc. EBS which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is EXAS going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.